Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Light-based Immunomodulation for Guarding Against Human Respiratory Tract Infections

NCT: NCT07610967 · RECRUITING

NCT IDNCT07610967
StatusRECRUITING
Start Date2026-10-01
SponsorDavid Moss (FED)
First posted
Last updated

Brief Summary

The purpose of trial is to determine if daily usage of a photobiomodulation device will decrease the incidence of upper respiratory tract infections (URI) due to COVID, influenza or other viruses.The RD-X10 device is handheld, can be self-administered, and has been shown to be safe in invivo studies.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑